RefleXion Stock
HealthTechLooking to sell RefleXion stock or options?
RefleXion is the developer of a unique biology-guided radiotherapy intended to revolutionize cancer treatment modalities. Their innovative radiotherapy uses positron emission tomography (PET) in a distinctive manner, combining it with stereotactic radiotherapy for enhanced tumor localization and tracking during treatment delivery. This enables physicians to precisely pinpoint the location of cancer cells and effectively destroy them.
T. Rowe Price Group, National Cancer Institute, KCK MedTech, Ascension Ventures, Hillenbrand Capital Partners, Sixty Degree Capital, Ally Bridge Group, Public Sector Pension Investment Board, Johnson & Johnson Innovation - JJDC, The Rise Fund, KCK Group, Sofinnova Partners, Inspovation Ventures, TPG, Pimlico Pond Investments, Catalio Capital Management, GT Healthcare Capital Partners, EXOR Seeds, Venrock, Pfizer Ventures.